Brazilian Journal of Medical and Biological Research (BRAZ J MED BIOL RES )

Publisher: Associação Brasileira de Divulgação Científica

Journal description

Publication of the Associação Brasileira de Divulgação Científica. Mission: To publish the results of original research which contribute significantly to knowledge in medical and biological sciences. Former Title: Revista brasileira de pesquisas médicas e biológicas.

Current impact factor: 1.03

Impact Factor Rankings

2015 Impact Factor Available summer 2015
2013 / 2014 Impact Factor 1.034
2012 Impact Factor 1.139
2011 Impact Factor 1.129
2010 Impact Factor 1.15
2009 Impact Factor 1.075
2008 Impact Factor 1.215
2007 Impact Factor 1.15
2006 Impact Factor 1.075
2005 Impact Factor 0.859
2004 Impact Factor 0.824
2003 Impact Factor 0.74
2002 Impact Factor 0.802
2001 Impact Factor 0.769
2000 Impact Factor 0.654
1999 Impact Factor 0.517
1998 Impact Factor 0.439
1997 Impact Factor 0.468
1996 Impact Factor 0.455
1995 Impact Factor 0.383
1994 Impact Factor 0.296
1993 Impact Factor 0.276
1992 Impact Factor 0.389

Impact factor over time

Impact factor

Additional details

5-year impact 1.36
Cited half-life 8.60
Immediacy index 0.13
Eigenfactor 0.01
Article influence 0.35
Website Brazilian Journal of Medical and Biological Research website
Other titles Brazilian journal of medical and biological research (Online)
ISSN 0100-879X
OCLC 46982630
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publications in this journal

  • Brazilian Journal of Medical and Biological Research 12/2014;
  • Brazilian Journal of Medical and Biological Research 01/2014; 47:35-41.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The duties of humans toward non-human animals and their rights in society have been debated for a long time. However, a discussion on the terminology used for the identification of laboratory animals is usually not considered, although the employment of inadequate terminology may generate disastrous consequences for the animals before, during, and after the experiment. This study intends to defend the use of appropriate terminology, call attention to an unethical attitude of certain professionals when dealing with experimental animals, and also propose operational mechanisms, which allow for those distortions to be corrected.
    Brazilian Journal of Medical and Biological Research 01/2014; 47(1):19-23.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Exaggerated blood pressure response (EBPR) during the exercise treadmill test (ETT) has been considered to be a risk factor for hypertension. The relationship of polymorphisms of the renin-angiotensin system gene with hypertension has not been established. Our objective was to evaluate whether EBPR during exercise is a clinical marker for hypertension. The study concerned a historical cohort of normotensive individuals. The exposed individuals were those who presented EBPR. At the end of the observation period (41.7 months = 3.5 years), the development of hypertension was analyzed within the two groups. Genetic polymorphisms and blood pressure behavior were assessed as independent variables, together with the classical risk factors for hypertension. The I/D gene polymorphism of the angiotensin-converting enzyme and M235T of angiotensinogen were ruled out as risk factors for hypertension. EBPR during ETT is not an independent influence on the chances of developing hypertension. No differences were observed between the hypertensive and normotensive individuals regarding gender (P = 0.655), skin color (P = 0.636), family history of hypertension (P = 0.225), diabetes mellitus (P = 0.285), or hypertriglyceridemia (P = 0.734). The risk of developing hypertension increased with increasing body mass index (BMI) and advancing age. The risk factors, which independently influenced the development of hypertension, were age and BMI. EBPR did not constitute an independent risk factor for hypertension and is probably a preclinical phase in the spectrum of normotension and hypertension.
    Brazilian Journal of Medical and Biological Research 04/2013; 46(4):368-347.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective this study was to determine the effect of phytohemagglutinin (PHA) on survival, growth and gene expression in caprine secondary follicles cultured in vitro. Secondary follicles (∼0.2 mm) were isolated from the cortex of caprine ovaries and cultured individually for 6 days in α-MEM+ supplemented with PHA (0, 1, 10, 50, 100, or 200 µg/mL). After 6 days of culture, follicle diameter and survival, antrum formation, ultrastructure and expression of mRNA for FSH receptors (FSH-R), proliferating cell nuclear antigen (PCNA), and neuronal nitric oxide synthase were determined. All treatments maintained follicular survival [α-MEM+ (94.59%); 1 µg/mL PHA (96.43%); 10 µg/mL PHA (84.85%); 50 µg/mL PHA (85.29%); 100 µg/mL PHA (88.57%), and 200 µg/mL PHA (87.50)], but the presence of 10 µg/mL PHA in the culture medium increased the antrum formation rate (21.21%) when compared with control (5.41%, P < 0.05) and ensured the maintenance of oocyte and granulosa cell ultrastructures after 6 days of culture. The expression of mRNA for FSH-R (2.7 ± 0.1) and PCNA (4.4 ± 0.2) was also significantly increased in follicles cultured with 10 µg/mL PHA in relation to those cultured in α-MEM+ (1.0 ± 0.1). In conclusion, supplementation of culture medium with 10 µg/mL PHA maintains the follicular viability and ultrastructure, and promotes the formation of antral cavity after 6 days of culture in vitro.
    Brazilian Journal of Medical and Biological Research 03/2013; 46(3):245-252.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Studies on the assessment of heart rate variability threshold (HRVT) during walking are scarce. We determined the reliability and validity of HRVT assessment during the incremental shuttle walk test (ISWT) in healthy subjects. Thirty-one participants aged 57 ± 9 years (17 females) performed 3 ISWTs. During the 1st and 2nd ISWTs, instantaneous heart rate variability was calculated every 30 s and HRVT was measured. Walking velocity at HRVT in these tests (WV-HRVT1 and WV-HRVT2) was registered. During the 3rd ISWT, physiological responses were assessed. The ventilatory equivalents were used to determine ventilatory threshold (VT) and the WV at VT (WV-VT) was recorded. The difference between WV-HRVT1 and WV-HRVT2 was not statistically significant (median and interquartile range = 4.8; 4.8 to 5.4 vs 4.8; 4.2 to 5.4 km/h); the correlation between WV-HRVT1 and WV-HRVT2 was significant (r = 0.84); the intraclass correlation coefficient was high (0.92; 0.82 to 0.96), and the agreement was acceptable (-0.08 km/h; -0.92 to 0.87). The difference between WV-VT and WV-HRVT2 was not statistically significant (4.8; 4.8 to 5.4 vs 4.8; 4.2 to 5.4 km/h) and the agreement was acceptable (0.04 km/h; -1.28 to 1.36). HRVT assessment during walking is a reliable measure and permits the estimation of VT in adults. We suggest the use of the ISWT for the assessment of exercise capacity in middle-aged and older adults.
    Brazilian Journal of Medical and Biological Research 02/2013; 46(2):194-199.